Severe Comorbidity Burden Does Not Influence Postoperative Clinical Outcomes and Trajectory for Back Pain, Leg Pain, Physical Function, or Disability in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion: Cohort-Matched Analysis

被引:1
|
作者
Jacob, Kevin C. [1 ]
Patel, Madhav R. [1 ]
Vanjani, Nisheka N. [1 ]
Pawlowski, Hanna [1 ]
Prabhu, Michael C. [1 ]
Park, Grant J. [1 ]
Collins, Andrew P. [1 ]
Singh, Kern [1 ]
机构
[1] Rush Univ, Dept Orthopaed Surg, Med Ctr, Chicago, IL 60612 USA
关键词
Back pain; Comorbidity; Leg pain; MIS-TLIF; Physical function; SPINE SURGERY; IMPACT;
D O I
10.1016/j.wneu.2022.04.058
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: To compare perioperative outcomes, patient-reported outcome measures (PROMs), and minimum clinically important difference achievement after single-level transforaminal lumbar interbody fusion (TLIF) in patients stratified by preoperative comorbidity burden. METHODS: PROMs were administered preoperatively/postoperatively and included Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS-PF), visual analog scale (VAS), Oswestry Disability Index (ODI), and 12-Item Short-Form Physical Composite Score (SF-12 PCS). Patients were grouped according to preoperative Charlson Comorbidity Index (CCI) <5 (mild to moderate comorbidity) or preoperative CCI >= 5 (severe preoperative comorbidity). A 3:1 propensity score match for age, gender, insurance status, smoking status, and preoperative spinal disease was used to control for significant demographic differences between cohorts. RESULTS: After propensity score matching, 255 patients were included (135 in the CCI <5 cohort; 120 in the CCI >= 5 cohort). The CCI >= 5 cohort showed significantly reduced postoperative VAS back pain score on the day of surgery (P < 0.001, all). Mean PROM differences were noted for postoperative PROMs: VAS back and ODI 6 months, both instances favoring the CCI >= 5 cohort (P < 0.038). The CCI <5 cohort improved from baseline to 1 year for all postoperative PROMs except SF-12 PCS 6 weeks and 12 weeks and SF-12 Mental Composite Score 6 weeks (P < 0.034, all). The CCI >= 5 cohort reported significant improvement from preoperative baseline to 1 year for all postoperative PROMs except ODI 6 weeks, SF-12 Mental Composite Score 6 weeks and 1 year, SF-12 PCS 6 weeks, and PROMIS-PF 6 weeks (P < 0.017, all). Both cohorts reported >50% overall minimum clinically important difference achievement rate for VAS leg, VAS back, ODI, SF-12 PCS, and PROMIS-PF. CONCLUSIONS: The results suggest that patients undergoing MIS TLIF with severe comorbidities can expect a similar postoperative trajectory for disability, leg and back pain, and physical function. However, long-term (1 year) mental health improvement from preoperative baseline was noted only in the mild to moderate comorbidity group.
引用
收藏
页码:E157 / E168
页数:12
相关论文
共 8 条
  • [1] The Impact of Comorbidity Burden on Postoperative PROMIS Physical Function Following Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Parrish, James M.
    Jenkins, Nathaniel W.
    Hrynewycz, Nadia M.
    Brundage, Thomas S.
    Yoo, Joon S.
    Singh, Kern
    CLINICAL SPINE SURGERY, 2020, 33 (06): : E294 - E298
  • [2] Obesity Does Not Adversely Affect Longterm Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Matched Cohort Analysis
    Coban, Daniel
    Changoor, Stuart
    Saela, Stephen
    Sinha, Kumar
    Hwang, K.
    Faloon, Michael
    Emami, Arash
    ORTHOPEDICS, 2022, 45 (04) : 203 - 208
  • [3] PROMIS Physical Function for prediction of postoperative pain, narcotics consumption, and patient-reported outcomes following minimally invasive transforaminal lumbar interbody fusion
    Patel, Dil, V
    Bawa, Mundeep S.
    Haws, Brittany E.
    Khechen, Benjamin
    Block, Andrew M.
    Karmarkar, Sailee S.
    Lamoutte, Eric H.
    Singh, Kern
    JOURNAL OF NEUROSURGERY-SPINE, 2019, 30 (04) : 476 - 482
  • [4] Worse Pain and Disability at Presentation Predicts Greater Improvement in Pain, Disability, and Mental Health in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Spondylolisthesis
    Anwar, Fatima N.
    Roca, Andrea M.
    Hartman, Timothy J.
    Nie, James W.
    Medakkar, Srinath S.
    Loya, Alexandra C.
    Macgregor, Keith R.
    Oyetayo, Omolabake O.
    Zheng, Eileen
    Federico, Vincent P.
    Sayari, Arash J.
    Lopez, Gregory D.
    Singh, Kern
    CLINICAL SPINE SURGERY, 2025, 38 (01): : 11 - 17
  • [5] The influence of age on the peri- and postoperative clinical course in patients undergoing minimally invasive transforaminal lumbar interbody fusion techniques of the lumbar spine
    Senker, Wolfgang
    Stefanits, Harald
    Gmeiner, Matthias
    Trutschnig, Wolfgang
    Radl, Christian
    Gruber, Andreas
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2019, 182 : 25 - 31
  • [6] Does the Predominant Pain Location Influence Functional Outcomes, Satisfaction, and Return to Work After Minimally Invasive Transforaminal Lumbar Interbody Fusion For Degenerative Spondylolisthesis?
    Goh, Graham S.
    Yue, Wai-Mun
    Guo, Chang Ming
    Tan, Seang-Beng
    Chen, John Li-Tat
    CLINICAL SPINE SURGERY, 2022, 35 (01): : E143 - E149
  • [7] Minimally Invasive Transforaminal Versus Lateral Lumbar Interbody Fusion for Degenerative Spinal Pathology Clinical Outcome Comparison in Patients With Predominant Back Pain
    Jacob, Kevin C.
    Patel, Madhav R.
    Hartman, Timothy J.
    Nie, James W.
    Parsons, Alexander W.
    Ribot, Max A.
    Prabhu, Michael
    Pawlowski, Hanna
    Vanjani, Nisheka
    Singh, Kern
    CLINICAL SPINE SURGERY, 2024, 37 (10): : E441 - E447
  • [8] Impact of Time to Surgery for Patients Using Workers' Compensation Insurance Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Preliminary Analysis of Clinical Outcomes
    Patel, Madhav R.
    Jacob, Kevin C.
    Lynch, Conor P.
    Cha, Elliot D. K.
    Patel, Saajan D.
    Prabhu, Michael C.
    Vanjani, Nisheka N.
    Pawlowski, Hanna
    Singh, Kern
    WORLD NEUROSURGERY, 2022, 160 : E421 - E429